After Acute Ischemic Stroke Market, Global Outlook and Forecast 2023-2029

Report ID: MMG236974 | Category: Service & Software | Pages: 60 | Format: PDF | Published Date: September 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for After Acute Ischemic Stroke, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding After Acute Ischemic Stroke. This report contains market size and forecasts of After Acute Ischemic Stroke in global, including the following market information:
Global After Acute Ischemic Stroke Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global After Acute Ischemic Stroke market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antihypertensive Therapeutics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of After Acute Ischemic Stroke include Bayer, Boehringer Ingelheim, Roche, Sanofi, Biogen, Daiichi Sankyo and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the After Acute Ischemic Stroke companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global After Acute Ischemic Stroke Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global After Acute Ischemic Stroke Market Segment Percentages, by Type, 2022 (%)
    Antihypertensive Therapeutics
    Antiplatelet Therapeutics
    Anticoagulants
Global After Acute Ischemic Stroke Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global After Acute Ischemic Stroke Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Ambulatory Surgical Center
    Diagnostic Centers
Global After Acute Ischemic Stroke Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global After Acute Ischemic Stroke Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies After Acute Ischemic Stroke revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies After Acute Ischemic Stroke revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bayer
    Boehringer Ingelheim
    Roche
    Sanofi
    Biogen
    Daiichi Sankyo
    Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of After Acute Ischemic Stroke, market overview.
Chapter 2: Global After Acute Ischemic Stroke market size in revenue.
Chapter 3: Detailed analysis of After Acute Ischemic Stroke company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of After Acute Ischemic Stroke in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 After Acute Ischemic Stroke Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global After Acute Ischemic Stroke Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global After Acute Ischemic Stroke Overall Market Size
    2.1 Global After Acute Ischemic Stroke Market Size: 2022 VS 2029
    2.2 Global After Acute Ischemic Stroke Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top After Acute Ischemic Stroke Players in Global Market
    3.2 Top Global After Acute Ischemic Stroke Companies Ranked by Revenue
    3.3 Global After Acute Ischemic Stroke Revenue by Companies
    3.4 Top 3 and Top 5 After Acute Ischemic Stroke Companies in Global Market, by Revenue in 2022
    3.5 Global Companies After Acute Ischemic Stroke Product Type
    3.6 Tier 1, Tier 2 and Tier 3 After Acute Ischemic Stroke Players in Global Market
        3.6.1 List of Global Tier 1 After Acute Ischemic Stroke Companies
        3.6.2 List of Global Tier 2 and Tier 3 After Acute Ischemic Stroke Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global After Acute Ischemic Stroke Market Size Markets, 2022 & 2029
        4.1.2 Antihypertensive Therapeutics
        4.1.3 Antiplatelet Therapeutics
        4.1.4 Anticoagulants
    4.2 By Type - Global After Acute Ischemic Stroke Revenue & Forecasts
        4.2.1 By Type - Global After Acute Ischemic Stroke Revenue, 2018-2023
        4.2.2 By Type - Global After Acute Ischemic Stroke Revenue, 2024-2029
        4.2.3 By Type - Global After Acute Ischemic Stroke Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global After Acute Ischemic Stroke Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Ambulatory Surgical Center
        5.1.4 Diagnostic Centers
    5.2 By Application - Global After Acute Ischemic Stroke Revenue & Forecasts
        5.2.1 By Application - Global After Acute Ischemic Stroke Revenue, 2018-2023
        5.2.2 By Application - Global After Acute Ischemic Stroke Revenue, 2024-2029
        5.2.3 By Application - Global After Acute Ischemic Stroke Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global After Acute Ischemic Stroke Market Size, 2022 & 2029
    6.2 By Region - Global After Acute Ischemic Stroke Revenue & Forecasts
        6.2.1 By Region - Global After Acute Ischemic Stroke Revenue, 2018-2023
        6.2.2 By Region - Global After Acute Ischemic Stroke Revenue, 2024-2029
        6.2.3 By Region - Global After Acute Ischemic Stroke Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America After Acute Ischemic Stroke Revenue, 2018-2029
        6.3.2 US After Acute Ischemic Stroke Market Size, 2018-2029
        6.3.3 Canada After Acute Ischemic Stroke Market Size, 2018-2029
        6.3.4 Mexico After Acute Ischemic Stroke Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe After Acute Ischemic Stroke Revenue, 2018-2029
        6.4.2 Germany After Acute Ischemic Stroke Market Size, 2018-2029
        6.4.3 France After Acute Ischemic Stroke Market Size, 2018-2029
        6.4.4 U.K. After Acute Ischemic Stroke Market Size, 2018-2029
        6.4.5 Italy After Acute Ischemic Stroke Market Size, 2018-2029
        6.4.6 Russia After Acute Ischemic Stroke Market Size, 2018-2029
        6.4.7 Nordic Countries After Acute Ischemic Stroke Market Size, 2018-2029
        6.4.8 Benelux After Acute Ischemic Stroke Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia After Acute Ischemic Stroke Revenue, 2018-2029
        6.5.2 China After Acute Ischemic Stroke Market Size, 2018-2029
        6.5.3 Japan After Acute Ischemic Stroke Market Size, 2018-2029
        6.5.4 South Korea After Acute Ischemic Stroke Market Size, 2018-2029
        6.5.5 Southeast Asia After Acute Ischemic Stroke Market Size, 2018-2029
        6.5.6 India After Acute Ischemic Stroke Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America After Acute Ischemic Stroke Revenue, 2018-2029
        6.6.2 Brazil After Acute Ischemic Stroke Market Size, 2018-2029
        6.6.3 Argentina After Acute Ischemic Stroke Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa After Acute Ischemic Stroke Revenue, 2018-2029
        6.7.2 Turkey After Acute Ischemic Stroke Market Size, 2018-2029
        6.7.3 Israel After Acute Ischemic Stroke Market Size, 2018-2029
        6.7.4 Saudi Arabia After Acute Ischemic Stroke Market Size, 2018-2029
        6.7.5 UAE After Acute Ischemic Stroke Market Size, 2018-2029
7 After Acute Ischemic Stroke Companies Profiles
    7.1 Bayer
        7.1.1 Bayer Company Summary
        7.1.2 Bayer Business Overview
        7.1.3 Bayer After Acute Ischemic Stroke Major Product Offerings
        7.1.4 Bayer After Acute Ischemic Stroke Revenue in Global Market (2018-2023)
        7.1.5 Bayer Key News & Latest Developments
    7.2 Boehringer Ingelheim
        7.2.1 Boehringer Ingelheim Company Summary
        7.2.2 Boehringer Ingelheim Business Overview
        7.2.3 Boehringer Ingelheim After Acute Ischemic Stroke Major Product Offerings
        7.2.4 Boehringer Ingelheim After Acute Ischemic Stroke Revenue in Global Market (2018-2023)
        7.2.5 Boehringer Ingelheim Key News & Latest Developments
    7.3 Roche
        7.3.1 Roche Company Summary
        7.3.2 Roche Business Overview
        7.3.3 Roche After Acute Ischemic Stroke Major Product Offerings
        7.3.4 Roche After Acute Ischemic Stroke Revenue in Global Market (2018-2023)
        7.3.5 Roche Key News & Latest Developments
    7.4 Sanofi
        7.4.1 Sanofi Company Summary
        7.4.2 Sanofi Business Overview
        7.4.3 Sanofi After Acute Ischemic Stroke Major Product Offerings
        7.4.4 Sanofi After Acute Ischemic Stroke Revenue in Global Market (2018-2023)
        7.4.5 Sanofi Key News & Latest Developments
    7.5 Biogen
        7.5.1 Biogen Company Summary
        7.5.2 Biogen Business Overview
        7.5.3 Biogen After Acute Ischemic Stroke Major Product Offerings
        7.5.4 Biogen After Acute Ischemic Stroke Revenue in Global Market (2018-2023)
        7.5.5 Biogen Key News & Latest Developments
    7.6 Daiichi Sankyo
        7.6.1 Daiichi Sankyo Company Summary
        7.6.2 Daiichi Sankyo Business Overview
        7.6.3 Daiichi Sankyo After Acute Ischemic Stroke Major Product Offerings
        7.6.4 Daiichi Sankyo After Acute Ischemic Stroke Revenue in Global Market (2018-2023)
        7.6.5 Daiichi Sankyo Key News & Latest Developments
    7.7 Pfizer
        7.7.1 Pfizer Company Summary
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer After Acute Ischemic Stroke Major Product Offerings
        7.7.4 Pfizer After Acute Ischemic Stroke Revenue in Global Market (2018-2023)
        7.7.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

After Acute Ischemic Stroke Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?